Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1946 1
1955 1
1957 1
1959 2
1968 4
1969 4
1970 1
1971 4
1972 4
1973 12
1974 20
1975 27
1976 25
1977 20
1978 9
1979 9
1980 6
1981 6
1982 9
1983 17
1984 9
1985 9
1986 13
1987 10
1988 16
1989 5
1990 11
1991 11
1992 6
1993 11
1994 5
1995 8
1996 10
1997 5
1998 3
1999 3
2000 11
2001 18
2002 16
2003 14
2004 12
2005 22
2006 16
2007 7
2008 12
2009 8
2010 15
2011 14
2012 7
2013 3
2014 3
2015 5
2016 2
2017 7
2018 10
2019 10
2020 7
2021 9
2022 6
2023 12
2024 4
2025 7

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

552 results

Results by year

Filters applied: . Clear all
Page 1
A deep-learning framework to predict cancer treatment response from histopathology images through imputed transcriptomics.
Hoang DT, Dinstag G, Shulman ED, Hermida LC, Ben-Zvi DS, Elis E, Caley K, Sammut SJ, Sinha S, Sinha N, Dampier CH, Stossel C, Patil T, Rajan A, Lassoued W, Strauss J, Bailey S, Allen C, Redman J, Beker T, Jiang P, Golan T, Wilkinson S, Sowalsky AG, Pine SR, Caldas C, Gulley JL, Aldape K, Aharonov R, Stone EA, Ruppin E. Hoang DT, et al. Among authors: redman j. Nat Cancer. 2024 Sep;5(9):1305-1317. doi: 10.1038/s43018-024-00793-2. Epub 2024 Jul 3. Nat Cancer. 2024. PMID: 38961276 Free PMC article.
Cancer Risks Associated With Germline PALB2 Pathogenic Variants: An International Study of 524 Families.
Yang X, Leslie G, Doroszuk A, Schneider S, Allen J, Decker B, Dunning AM, Redman J, Scarth J, Plaskocinska I, Luccarini C, Shah M, Pooley K, Dorling L, Lee A, Adank MA, Adlard J, Aittomäki K, Andrulis IL, Ang P, Barwell J, Bernstein JL, Bobolis K, Borg Å, Blomqvist C, Claes KBM, Concannon P, Cuggia A, Culver JO, Damiola F, de Pauw A, Diez O, Dolinsky JS, Domchek SM, Engel C, Evans DG, Fostira F, Garber J, Golmard L, Goode EL, Gruber SB, Hahnen E, Hake C, Heikkinen T, Hurley JE, Janavicius R, Kleibl Z, Kleiblova P, Konstantopoulou I, Kvist A, Laduca H, Lee ASG, Lesueur F, Maher ER, Mannermaa A, Manoukian S, McFarland R, McKinnon W, Meindl A, Metcalfe K, Mohd Taib NA, Moilanen J, Nathanson KL, Neuhausen S, Ng PS, Nguyen-Dumont T, Nielsen SM, Obermair F, Offit K, Olopade OI, Ottini L, Penkert J, Pylkäs K, Radice P, Ramus SJ, Rudaitis V, Side L, Silva-Smith R, Silvestri V, Skytte AB, Slavin T, Soukupova J, Tondini C, Trainer AH, Unzeitig G, Usha L, van Overeem Hansen T, Whitworth J, Wood M, Yip CH, Yoon SY, Yussuf A, Zogopoulos G, Goldgar D, Hopper JL, Chenevix-Trench G, Pharoah P, George SHL, Balmaña J, Houdayer C, James P, El-Haffaf Z, Ehrencrona H, Janatova M, Peterlongo P, … See abstract for full author list ➔ Yang X, et al. Among authors: redman j. J Clin Oncol. 2020 Mar 1;38(7):674-685. doi: 10.1200/JCO.19.01907. Epub 2019 Dec 16. J Clin Oncol. 2020. PMID: 31841383 Free PMC article.
Novel immunotherapy combinations for genitourinary cancers.
Al Harthy M, Redman J, Madan RA. Al Harthy M, et al. Among authors: redman j. Expert Opin Biol Ther. 2020 Mar;20(3):253-262. doi: 10.1080/14712598.2020.1713086. Epub 2020 Jan 27. Expert Opin Biol Ther. 2020. PMID: 31914333 Review.
Phenotypic plasticity and reduced tissue retention of exhausted tumor-infiltrating T cells following neoadjuvant immunotherapy in head and neck cancer.
Sievers C, Craveiro M, Friedman J, Robbins Y, Yang X, Bai K, Nguyen A, Redman JM, Chari R, Soon-Shiong P, Schlom J, Gulley J, Allen CT. Sievers C, et al. Among authors: redman jm. Cancer Cell. 2023 May 8;41(5):887-902.e5. doi: 10.1016/j.ccell.2023.03.014. Epub 2023 Apr 13. Cancer Cell. 2023. PMID: 37059104 Free PMC article.
Advances in immunotherapy for melanoma.
Redman JM, Gibney GT, Atkins MB. Redman JM, et al. BMC Med. 2016 Feb 6;14:20. doi: 10.1186/s12916-016-0571-0. BMC Med. 2016. PMID: 26850630 Free PMC article. Review.
Editorial comment.
Redman JF. Redman JF. J Urol. 2009 Oct;182(4 Suppl):1754; discussion 1754. doi: 10.1016/j.juro.2009.03.088. Epub 2009 Aug 18. J Urol. 2009. PMID: 19692093 No abstract available.
Novel Combination Immunotherapy and Clinical Activity in Patients With HPV-Associated Cancers: A Nonrandomized Clinical Trial.
Floudas CS, Goswami M, Donahue RN, Pastor DM, Redman JM, Brownell I, Turkbey EB, Cordes LM, Steinberg SM, Manu M, Francis DC, Lamping E, Marté JL, Kackley M, Krauss E, Manukyan M, Jochems C, Schlom J, Gulley JL, Strauss J. Floudas CS, et al. Among authors: redman jm. JAMA Oncol. 2025 Apr 1;11(4):394-399. doi: 10.1001/jamaoncol.2024.6998. JAMA Oncol. 2025. PMID: 39976981 Free PMC article. Clinical Trial.
PRGN-2009 and bintrafusp alfa for patients with advanced or metastatic human papillomavirus-associated cancer.
Floudas CS, Goswami M, Donahue RN, Strauss J, Pastor DM, Redman JM, Brownell I, Turkbey EB, Steinberg SM, Cordes LM, Marté JL, Khan MH, McMahon S, Lamping E, Manu M, Manukyan M, Brough DE, Lankford A, Jochems C, Schlom J, Gulley JL. Floudas CS, et al. Among authors: redman jm. Cancer Immunol Immunother. 2025 Mar 21;74(5):155. doi: 10.1007/s00262-025-04009-z. Cancer Immunol Immunother. 2025. PMID: 40116923 Free PMC article. Clinical Trial.
552 results